Cargando…

The role of complement in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic liver diseases globally. NAFLD includes a range of hepatic manifestations, starting with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis, cirrhosis or even hepatocellular carcinoma. Although...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Zhenya, Fan, Xiude, Yao, Jianni, Tomlinson, Stephen, Yuan, Guandou, He, Songqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562907/ https://www.ncbi.nlm.nih.gov/pubmed/36248852 http://dx.doi.org/10.3389/fimmu.2022.1017467

Ejemplares similares

Editorial: New insights into the role of complement system in liver diseases
por: Guo, Zhenya, et al.
Publicado: (2023)

Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
por: Guo, Zhenya, et al.
Publicado: (2022)

The role of the complosome in health and disease
por: Xiao, Fang, et al.
Publicado: (2023)

Roles of the complement system in alcohol-induced liver disease
por: Zhou, Yi, et al.
Publicado: (2020)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease
por: Fa, Pengyan, et al.
Publicado: (2023)

Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis
por: Zhong, Fudi, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
por: Barbarroja, Nuria, et al.
Publicado: (2022)

Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation
por: Zheng, Chaowen, et al.
Publicado: (2021)

Comparison of surgical outcomes among open, laparoscopic, and robotic pancreatoduodenectomy: a single-center retrospective study
por: Guo, Wei, et al.
Publicado: (2022)

The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease
por: Zhao, Enfa, et al.
Publicado: (2023)

Role of Mitochondria in Nonalcoholic Fatty Liver Disease
por: Nassir, Fatiha, et al.
Publicado: (2014)

The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
por: Frasinariu, Otilia, et al.
Publicado: (2022)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization
por: Li, Yanmei, et al.
Publicado: (2018)

Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice
por: Yamazaki, Kyoko, et al.
Publicado: (2021)

Complement in the Homeostatic and Ischemic Brain
por: Alawieh, Ali, et al.
Publicado: (2015)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Emerging role of engineered exosomes in nonalcoholic fatty liver disease
por: Ding, Jian, et al.
Publicado: (2023)

Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease
por: Huang, Ruixian, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Complementing regeneration
por: Alawieh, Ali, et al.
Publicado: (2015)

Modulation of the Complement System by Neoplastic Disease of the Central Nervous System
por: Yarmoska, Steven K., et al.
Publicado: (2021)

The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease
por: Roychowdhury, Sanjoy, et al.
Publicado: (2018)

Role of cenicriviroc in the management of nonalcoholic fatty liver disease
por: Neokosmidis, Georgios, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease in Diabetics: The Role of Hepatologist
por: Khandelwal, Reshu, et al.
Publicado: (2022)

Role of extracellular vesicles in nonalcoholic fatty liver disease
por: Jiang, Wei, et al.
Publicado: (2023)

A Healthful Plant-Based Diet Is Associated with Lower Odds of Nonalcoholic Fatty Liver Disease
por: Li, Xiude, et al.
Publicado: (2022)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults
por: Ying, Xin, et al.
Publicado: (2012)

Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease
por: Yang, Weijia, et al.
Publicado: (2019)

Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning
por: Ouyang, Guoqing, et al.
Publicado: (2023)

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation
por: Zhou, Jingxuan, et al.
Publicado: (2022)

Bidirectional Association Between Psoriasis and Nonalcoholic Fatty Liver Disease: Real-World Evidence From Two Longitudinal Cohort Studies
por: Gau, Shuo-Yan, et al.
Publicado: (2022)

Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells
por: Li, Baochen, et al.
Publicado: (2022)

The C1q-ApoE complex: A new hallmark pathology of viral hepatitis and nonalcoholic fatty liver disease
por: Habenicht, Livia K. L., et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation
por: Brunt, Elizabeth M.
Publicado: (2017)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3ad86ils7j66hm60sllu1ini0p